**BACKGROUND:** Rates of chronic regional pain syndrome (CRPS) following Dupuytren's contracture release remain unclear. Rates have been reported to range from 2.4% to 18.5% based on single institution case series.^1,2^ This study sought to provide a national perspective on the incidence of CRPS following treatment of Dupuytren's contracture and to identify patient factors to target for risk reduction.

**METHODS:** Using the MarketScan Outpatient Services and Medicare Supplemental Insurance Outpatient Services databases, individuals 18 years old or older who developed CRPS within 1 year of treatment of Dupuytren's contracture were identified using the *International Classification of Diseases* diagnosis code for CRPS type 1. Exclusion criteria included patients who had a prior diagnosis of CRPS, had \<1 year follow-up, or were treated concurrently with both collagenase injection and an operative procedure. Predictor variables included age, gender, comorbidities, employment status, region, and type of procedure. Patients who underwent a postoperative stellate ganglion block were also noted. Multivariable logistic regression was used to analyze outcomes.

**RESULTS:** A total of 48,317 patients received treatment for Dupuytren's contracture from 2007 to 2015. Average age was 61.9 years (SD, 10.5; range, 18--97 years), and 72.1% of patients were male. A minority of patients had comorbidities including diabetes mellitus (3.3%), obesity (0.6%), or active smoking (1.5%). Treatment for Dupuytren's contracture included collagenase injection (9.1%); closed palmar fasciotomy (5.7%); open palmar fasciotomy (2.5%); palmar fasciectomy with zero (7.7%), 1 (19.2%), or multiple (1.6%) digit releases; or a combination of operative procedures (55.2%). One hundred two patients (0.21%) were diagnosed with CRPS at a mean of 3.2 months (SD, 1.8; range, 0.3--9.0 months) following treatment for Dupuytren's contracture. Fifty-eight of these patients (56.9%) underwent postoperative stellate ganglion block. Significant predictors of CRPS included younger age (odds ratio \[OR\], 0.95; confidence interval \[CI\], 0.93--0.97; *P* \< 0.001), female gender (OR, 1.83; CI, 1.23--2.73; *P* = 0.003), Southern region (OR, 2.63; CI, 1.37--5.05; *P* = 0.004), palmar fasciectomy including release of 1 (OR, 9.37; CI, 1.27--69.11; *P* = 0.028) or \>1 digit (OR, 33.62; CI, 4.12--274.65; *P* = 0.015), and multiple operative procedures (OR, 11.62; CI, 1.60--84.41; *P* = 0.015).

**CONCLUSIONS:** Based on this study, the incidence of CRPS type 1 following treatment for Dupuytren's contracture is likely lower than previously reported. Risk factors include younger age, female gender, and more extensive operative procedures, particularly those involving fasciectomy with release of ≥1 digits. Patients with these characteristics should be targeted for pre- and postoperative risk reduction measures to limit the development of CRPS.
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